(CBRE) CBRE - NYSE
Sector: Real Estate | Industry: Real Estate Services | Exchange: NYSE (USA) | Market Cap: 39.065m USD | Total Return: -1.4% in 12m
Avg Turnover: 315M
EPS Trend: 87.3%
Qual. Beats: 1
Rev. Trend: 99.3%
Qual. Beats: 1
Warnings
Below Avwap Earnings
Tailwinds
No distinct edge detected
CBRE Group, Inc. is a global commercial real estate services and investment firm headquartered in Dallas, Texas. The company operates through four primary segments: Advisory Services, Building Operations and Experience, Project Management, and Real Estate Investments. Its service portfolio includes strategic leasing, property sales under the CBRE Capital Markets brand, mortgage financing, and valuation services for office, industrial, and retail properties.
The firm maintains a diversified business model that balances transactional revenue, such as property sales and leasing commissions, with recurring revenue streams from facilities management and long-term investment management. In the Real Estate Investments segment, CBRE manages capital for institutional investors and executes large-scale development projects through its Trammell Crow Company subsidiary. Assessing historical performance trends on ValueRay can provide further context on these business segments. Commercial real estate service providers like CBRE often benefit from high barriers to entry due to the extensive global networks and specialized data required to execute complex international transactions.
- Interest rate volatility dictates commercial transaction volumes and capital markets revenue
- Growth in outsourcing contracts provides resilient recurring revenue for building operations
- Global office vacancy rates impact leasing commissions and advisory services margins
- Expansion of project management services through Turner & Townsend diversifies earnings base
- Institutional capital flows influence assets under management and investment performance fees
| Net Income: 1.31b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -2.41 > 1.0 |
| NWC/Revenue: 2.33% < 20% (prev -0.10%; Δ 2.43% < -1%) |
| CFO/TA 0.04 > 3% & CFO 1.28b > Net Income 1.31b |
| Net Debt (8.69b) to EBITDA (2.68b): 3.24 < 3 |
| Current Ratio: 1.08 > 1.5 & < 3 |
| Outstanding Shares: last quarter (297.0m) vs 12m ago -1.96% < -2% |
| Gross Margin: 34.99% > 18% (prev 19.53%; Δ 15.46% > 0.5%) |
| Asset Turnover: 149.2% > 50% (prev 139.3%; Δ 9.82% > 0%) |
| Interest Coverage Ratio: 10.29 > 6 (EBIT TTM 2.00b / Interest Expense TTM 194.0m) |
| A: 0.03 (Total Current Assets 12.7b - Total Current Liabilities 11.8b) / Total Assets 30.2b |
| B: 0.32 (Retained Earnings 9.68b / Total Assets 30.2b) |
| C: 0.07 (EBIT TTM 2.00b / Avg Total Assets 28.3b) |
| D: 0.40 (Book Value of Equity 8.52b / Total Liabilities 21.3b) |
| Altman-Z'' = 2.15 = BBB |
| DSRI: 1.03 (Receivables 10.0b/8.46b, Revenue 42.2b/36.7b) |
| GMI: 0.56 (GM 19.53% / 34.99%) |
| AQI: 1.13 (AQ_t 0.54 / AQ_t-1 0.48) |
| SGI: 1.15 (Revenue 42.2b / 36.7b) |
| TATA: 0.00 (NI 1.31b - CFO 1.28b) / TA 30.2b) |
| Beneish M = -3.22 (Cap -4..+1) = AA |
As of June 19, 2026, the stock is trading at USD 131.55 with a total of 2,253,599 shares traded.
Over the past week, the price has changed by -0.27%,
over one month by +0.85%,
over three months by -1.76% and
over the past year by -1.44%.
CBRE has received a consensus analysts rating of 4.08. Therefore, it is recommended to buy CBRE.
- StrongBuy: 5
- Buy: 4
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 178.6 | 35.8% |
P/E Trailing = 30.4589
P/E Forward = 18.1488
P/S = 0.9257
P/B = 4.5851
P/EG = 0.7118
Revenue TTM = 42.2b USD
EBIT TTM = 2.00b USD
EBITDA TTM = 2.68b USD
Long Term Debt = 5.02b USD (from longTermDebt, last quarter)
Short Term Debt = 2.93b USD (from shortTermDebt, last quarter)
Debt = 10.4b USD (from shortLongTermDebtTotal, last quarter) + Leases 2.40b
Net Debt = 8.69b USD (calculated: Debt 10.4b - CCE 1.66b)
Enterprise Value = 47.8b USD (39.1b + Debt 10.4b - CCE 1.66b)
Interest Coverage Ratio = 10.29 (Ebit TTM 2.00b / Interest Expense TTM 194.0m)
EV/FCF = 53.24x (Enterprise Value 47.8b / FCF TTM 897.0m)
FCF Yield = 1.88% (FCF TTM 897.0m / Enterprise Value 47.8b)
FCF Margin = 2.13% (FCF TTM 897.0m / Revenue TTM 42.2b)
Net Margin = 3.11% (Net Income TTM 1.31b / Revenue TTM 42.2b)
Gross Margin = 34.99% ((Revenue TTM 42.2b - Cost of Revenue TTM 27.4b) / Revenue TTM)
Gross Margin QoQ = 17.59% (prev 15.29%)
Tobins Q-Ratio = 1.58 (Enterprise Value 47.8b / Total Assets 30.2b)
Interest Expense / Debt = 1.87% (Interest Expense 194.0m / Debt 10.4b)
Taxrate = 20.94% (378.0m / 1.80b)
NOPAT = 1.58b (EBIT 2.00b * (1 - 20.94%))
Current Ratio = 1.08 (Total Current Assets 12.7b / Total Current Liabilities 11.8b)
Debt / Equity = 1.22 (Debt 10.4b / totalStockholderEquity, last quarter 8.52b)
Debt / EBITDA = 3.24 (Net Debt 8.69b / EBITDA 2.68b)
Debt / FCF = 9.69 (Net Debt 8.69b / FCF TTM 897.0m)
Total Stockholder Equity = 8.55b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.64% (Net Income 1.31b / Total Assets 30.2b)
RoE = 15.35% (Net Income TTM 1.31b / Total Stockholder Equity 8.55b)
RoCE = 14.71% (EBIT 2.00b / Capital Employed (Equity 8.55b + L.T.Debt 5.02b))
RoIC = 8.02% (NOPAT 1.58b / Invested Capital 19.7b)
WACC = 7.35% (E(39.1b)/V(49.4b) * Re(8.91%) + D(10.4b)/V(49.4b) * Rd(1.87%) * (1-Tc(0.21)))
Discount Rate = 8.91% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -88.66 | Cagr: -1.68%
[DCF] Terminal Value 73.10% ; FCFF base≈1.11b ; Y1≈970.1m ; Y5≈783.8m
[DCF] Fair Price = 13.27 (EV 12.6b - Net Debt 8.69b = Equity 3.89b / Shares 292.8m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 87.28 | EPS CAGR: 23.94% | SUE: 1.37 | # QB: 1
Revenue Correlation: 99.29 | Revenue CAGR: 12.47% | SUE: 1.86 | # QB: 1
EPS current Quarter (2026-06-30): EPS=1.51 | Chg30d=-0.52% | Revisions=-43% | Analysts=12
EPS next Quarter (2026-09-30): EPS=1.84 | Chg30d=-1.40% | Revisions=-43% | Analysts=12
EPS current Year (2026-12-31): EPS=7.68 | Chg30d=+0.56% | Revisions=+43% | GrowthEPS=+20.3% | GrowthRev=+15.6%
EPS next Year (2027-12-31): EPS=8.87 | Chg30d=+0.10% | Revisions=+14% | GrowthEPS=+15.6% | GrowthRev=+8.8%
[Analyst] Revisions Ratio: -43%